GPNMB and metastatic prostate carcinoma: The dysregulation of GPNMB expression has been reported in many types of cancer, including hepatocellular carcinoma, malignant gliomas, and metastatic prostate cancer, and it is associated with the invasion and metastasis of tumor cells (7,8).